Flu infection study increases understanding of natural immunityJanuary 23, 2018
WHAT: People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according to a new study published in mBio. HA sits on the surface of the influenza virus to help bind it to cells and features a head and stem region. Scientists only recently discovered that humans naturally generate anti-HA stem antibodies in response to flu infection, and this is the first study of its kind to evaluate pre-existing levels of these specific antibodies as a predictor of protection against influenza. The findings could have implications for flu vaccine development, according to the authors. Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, conducted the research.
The study team has explored immune responses to two influenza surface proteins: HA--the main target of traditional seasonal flu vaccines--and neuraminidase (NA). The head region of HA is constantly changing, which is why influenza vaccine strains must be updated each year. The HA stem region, however, is less susceptible to change, making it a potential target for novel vaccines aimed at broader, more durable protection.
In the new analysis, investigators sought to understand the role of pre-existing anti-HA stem antibodies in protection against influenza using data from a healthy volunteer influenza challenge trial that took place in 2013 at the NIH Clinical Center in Bethesda, Maryland. Led by NIAID's Matthew J. Memoli, M.D., the trial enrolled 65 healthy volunteers aged 18 to 50 years. Participants stayed in a specially designed isolation and infection control unit throughout the study. Investigators measured participants' baseline levels of anti-HA stem antibodies, infected them with a 2009 H1N1 influenza virus, and then measured levels of anti-HA stem antibodies again.
They found that all volunteers had anti-HA stem antibodies at baseline, although levels varied, and 64 percent of participants had increased levels after infection. However, people with higher levels before exposure had smaller increases, suggesting there could be a limit that humans can achieve naturally. Trial investigators also closely monitored participants' symptoms and the amount of influenza virus they shed from the nose, which may indicate how contagious someone is. Similar to findings regarding anti-HA head antibodies, they found that participants with higher baseline levels of anti-HA stem antibodies had reduced viral shedding, but no significant reduction in the duration or severity of illness.
The results show that people naturally make anti-HA stem antibodies, but that responses vary significantly, and also these antibody levels are not independent predictors of whether someone becomes sick or if so, how severely. The authors note that antibodies against NA remain the only identified predictor of disease severity, according to previously reported trial data.
Although the data are limited, the results have implications for novel influenza vaccine design, according to the authors. They note future strategies ideally should focus on more than one aspect of immunity. "Careful consideration of the complexity of influenza immune protection and evaluation of all aspects of the anti-influenza immune responses will ultimately be necessary in the development of a successful broadly protective or universal influenza vaccine," the authors said.
WHO: NIAID Director Anthony S. Fauci, M.D., is available for comment. Matthew J. Memoli, M.D., director of the Clinical Studies Unit in NIAID's Laboratory of Infectious Diseases, is also available for comment.
CONTACT: To schedule interviews, please contact Jennifer Routh, (301) 402-1663, NIAIDNews@niaid.nih.gov.
NIAID conducts and supports research--at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH/National Institute of Allergy and Infectious Diseases
Related Influenza Articles:
An influenza infection in birds gives a good protection against other subtypes of the virus, like a natural vaccination, according to a new study.
Notre Dame Researchers have discovered a way to make influenza visible to the naked eye, by engineering dye molecules to target a specific enzyme of the virus.
How long does the protection from a mother's immunization against influenza during pregnancy last for infants after they are born?
Whilst countries in the tropics and subtropics exhibit diverse patterns of seasonal flu activity, they can be grouped into eight geographical zones to optimise vaccine formulation and delivery timing, according to a study published April 27, 2016 in the open-access journal PLOS ONE.
Influenza is able to mask itself, so that the virus is not initially detected by our immune system.
Team of scientists from the Icahn School of Medicine at Mount Sinai and Sanford Burnham Prebys Medical Discovery Institute among those who combined large genomic and proteomic datasets to identify novel host targets to treat flu.
Influenza pandemics are potentially the most serious natural catastrophes that affect the human population.
Lack of appropriate drugs and vaccines during the influenza A virus pandemic in 2009, the recent Ebola epidemic in West Africa, as well as the ongoing Middle Eastern Respiratory Syndrome-Coronavirus outbreak demonstrates that the world is only insufficiently prepared for global attacks of emerging infectious diseases and that the handling of such threats remains a great challenge.
In a new bioinformatics analysis of the H7N9 influenza virus that has recently infected humans in China, researchers trace the separate phylogenetic histories of the virus's genes, giving a frightening new picture of viruses where the genes are traveling independently in the environment, across large geographic distances and between species, to form 'a new constellation of genes -- a new disease, based not only on H7, but other strains of influenza.'
Influenza infection can enhance the ability of the bacterium Streptococcus pneumoniae to cause ear and throat infections, according to research published ahead of print in the journal Infection and Immunity.
Related Influenza Reading:
The Great Influenza: The Story of the Deadliest Pandemic in History
by John M. Barry (Author)
The definitive account of the 1918 Flu Epidemic. "Monumental"-Chicago Tribune.
At the height of WWI, history’s most lethal influenza virus erupted in an army camp in Kansas, moved east with American troops, then exploded, killing as many as 100 million people worldwide. It killed more people in twenty-four months than AIDS killed in twenty-four years, more in a year than the Black Death killed in a century. But this was not the Middle Ages, and 1918 marked the first collision of science and epidemic disease. Magisterial in its breadth of perspective and depth of research and now... View Details
Flu: The Story Of The Great Influenza Pandemic of 1918 and the Search for the Virus that Caused It
by Gina Kolata (Author)
A national bestseller, the fast-paced and gripping account of the Great Flu Epidemic of 1918 from acclaimed science journalist Gina Kolata, now featuring a new epilogue about avian flu.
When we think of plagues, we think of AIDS, Ebola, anthrax spores, and, of course, the Black Death. But in 1918 the Great Flu Epidemic killed an estimated forty million people virtually overnight. If such a plague returned today, taking a comparable percentage of the US population with it, 1.5 million Americans would die.
In Flu, Gina Kolata, an acclaimed reporter for The New York... View Details
Very, Very, Very Dreadful: The Influenza Pandemic of 1918
by Albert Marrin (Author)
From National Book Award finalist Albert Marrin comes a fascinating look at the history and science of the deadly 1918 flu pandemic--and the chances for another worldwide pandemic.
In spring of 1918, World War I was underway, and troops at Fort Riley, Kansas, found themselves felled by influenza. By the summer of 1918, the second wave struck as a highly contagious and lethal epidemic and within weeks exploded into a pandemic, an illness that travels rapidly from one continent to another. It would impact the course of the war, and kill many millions more soldiers than warfare... View Details
America's Forgotten Pandemic: The Influenza of 1918
by Alfred W. Crosby (Author)
Between August 1918 and March 1919 the Spanish influenza spread worldwide, claiming over 25 million lives, more people than those perished in the fighting of the First World War. It proved fatal to at least a half-million Americans. Yet, the Spanish flu pandemic is largely forgotten today. In this vivid narrative, Alfred W. Crosby recounts the course of the pandemic during the panic-stricken months of 1918 and 1919, measures its impact on American society, and probes the curious loss of national memory of this cataclysmic event. In a new edition, with a new preface discussing the recent... View Details
Influenza: A Century of Science and Public Health Response
by George Dehner (Author)
In 1976, the outbreak of a new strain of swine flu at the Fort Dix, New Jersey, army base prompted an unprecedented inoculation campaign. Some forty-two million Americans were vaccinated as the National Influenza Immunization Program hastened to prevent a pandemic, while the World Health Organization (WHO) took a wait-and-see approach. Fortunately, the virus did not spread, and only one death occurred. But instead of being lauded, American actions were subsequently denounced as a “fiasco” and instigator of mass panic.
In Influenza, George Dehner examines the wide... View Details
Pale Rider: The Spanish Flu of 1918 and How It Changed the World
by Laura Spinney (Author)
In 1918, the Italian-Americans of New York, the Yupik of Alaska and the Persians of Mashed had almost nothing in common except for a virus--one that triggered the worst pandemic of modern times and had a decisive effect on the history of the twentieth century.
The Spanish flu of 1918-1920 was one of the greatest human disasters of all time. It infected a third of the people on Earth--from the poorest immigrants of New York City to the king of Spain, Franz Kafka, Mahatma Gandhi and Woodrow Wilson. But despite a death toll of between 50 and 100 million people, it exists in our memory... View Details
Influenza: The Hundred Year Hunt to Cure the Deadliest Disease in History
by Dr Jeremy Brown (Author)
On the 100th anniversary of the devastating pandemic of 1918, Jeremy Brown, a veteran ER doctor, explores the troubling, terrifying, and complex history of the flu virus, from the origins of the Great Flu that killed millions, to vexing questions such as: are we prepared for the next epidemic, should you get a flu shot, and how close are we to finding a cure?
While influenza is now often thought of as a common and mild disease, it still kills over 30,000 people in the US each year. Dr. Jeremy Brown, currently Director of Emergency Care Research at the National Institutes of... View Details
The Influenza Pandemic of 1918-1919 (The Bedford Series in History and Culture)
by Susan K. Kent (Author)
The influenza pandemic of 1918-19 appeared suddenly at the end of the First World War and with explosive impact took the lives of at least 30 million people worldwide. Spreading rapidly across the globe, it defied all previous understandings of the disease, striking the youngest and healthiest individuals most acutely and confounding the doctors and governments who struggled to contain it. In this volume, Susan Kingsley Kent presents an overview of the disease, detailing its symptoms, tracking its spread, and offering insights into the medical community's understanding of and reaction to the... View Details
The Great Influenza: The Epic Story of the Deadliest Plague in History
by John M. Barry (Author)
In excellent condition View Details
Influenza: Viral Virulence (Volume 1)
by Steven C Ohliger (Author)
Michael was just a normal university student looking forward to graduating and starting a promising career. However, on the horizon, a dark, massive storm was building. Due to an extremely virulent flu strain and an ineffective vaccine, the world was about to experience the worst pandemic in history. With almost 90% of the population dead, Michael and his friends must keep their wits about them as society collapses and chaos reigns. Along with his friend, Lorie, he must escape and try to make his way home. Forced to deal with dwindling resources and vicious marauders, the couple... View Details